Impact of SARS-CoV-2 variants on inpatient clinical outcome.

Matthew L RobinsonC Paul MorrisJoshua F BetzYifan ZhangRobert BollingerNatalie WangDavid R ThiemannAmary FallRaghda E EldesoukiJulie M NortonDavid C GastonMichael FormanChun Huai LuoScott L ZegerAmita GuptaBrian T GaribaldiHeba H Mostafa

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

Although risk of severe disease or death for unvaccinated inpatients with Omicron was lower than Delta, it was similar to ancestral lineages. Severe outcomes were less common in vaccinated inpatients, with no difference between Delta and Omicron infections.

Keyphrases

sars cov
early onset
mental health
palliative care
copy number
respiratory syndrome coronavirus
drug induced
type diabetes
metabolic syndrome
gene expression
weight loss
insulin resistance